Royal Bank of Canada »

Lunai Bioworks shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Lunai Bioworks shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Lunai Bioworks

Tip: Access up to 7 years of quarterly data

All positions including Lunai Bioworks held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lunai Bioworks by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 146 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Lunai Bioworks

Vanguard Group
Millennium Management
BlackRock
Geode Capital Management
Renaissance Technologies
UBS Group
Susquehanna International
State Street Corporation
Northern Trust
Two Sigma Investments
Goldman Sachs Group
Commonwealth Equity Services
Tower Research Capital
Group One Trading
Bnp Paribas Arbitrage, Snc

View all funds holding Lunai Bioworks